Study Finds Women with Alzheimer’s Have Lower Levels of Healthy Fats

New research shows women with Alzheimer’s have lower levels of healthy fats, especially omega-3s, pointing to potential dietary strategies for prevention and management.
Women diagnosed with Alzheimer’s disease tend to have reduced levels of beneficial fats, particularly omega-3 fatty acids, compared to healthy women. A recent study from the UK analyzed lipid profiles in men and women with and without Alzheimer’s, revealing significant differences in women’s lipid levels. Women with the disease showed decreased levels of unsaturated lipids containing omega-3s like DHA and EPA, alongside an increase in unhealthy fats. Interestingly, no similar lipid pattern was observed in men with Alzheimer’s. Researchers suggest that boosting omega-3 intake through foods such as salmon, flaxseed, and edamame may offer protective benefits for women at risk. The study emphasizes the importance of personalized approaches in Alzheimer’s research and highlights potential dietary strategies to support brain health. While more research is needed, these findings underscore the role of lipid health in cognitive decline and disease prevention.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Mitochondrial Dysfunction and Myelin Loss Key Factors in Multiple Sclerosis Brain Damage
New research sheds light on how early mitochondrial impairment and myelin loss contribute to cerebellar damage in multiple sclerosis, offering hope for targeted therapies to protect brain health.
Link Between Vascular Risk Factors and Dementia: Insights from Recent Research
Emerging research links high blood pressure, diabetes, and smoking to increased dementia risk. Early intervention in vascular health may help prevent cognitive decline and Alzheimer’s disease.
Innovative Test Accurately Detects Brain Cancers Using Cerebrospinal Fluid
A novel multi-analyte test developed by Johns Hopkins researchers can accurately diagnose brain cancers from cerebrospinal fluid, offering a less invasive and highly reliable diagnostic tool.
S100A1 as a New Biomarker for Assessing Frailty in Elderly Patients with Heart Disease
New research identifies the gene S100A1 as a potential biomarker for frailty in older patients with heart disease, paving the way for improved diagnosis and targeted therapies to maintain muscle health and mobility.



